Finance

Lists
Why is BIOG-B up 2,62%?
Dive Deeper
BIOG-B:STO
BioGaia AB
121,40 SEK
+2,62%
(+3,10) 1D
13 қаз., 17:29:48 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for BIOG-B...
Open
118,60 SEK
High
121,80 SEK
Low
118,60 SEK
Mkt. cap
11,65 млрд
Avg. vol.
165,93 м.
Volume
307,56 м.
52-wk high
136,30 SEK
52-wk low
96,20 SEK
Shares outstanding
98,50 млн
No. of employees
251
Open
118,60 SEK
High
121,80 SEK
Low
118,60 SEK
Mkt. cap
11,65 млрд
Avg. vol.
165,93 м.
Volume
307,56 м.
52-wk high
136,30 SEK
52-wk low
96,20 SEK
Shares outstanding
98,50 млн
No. of employees
251
News stories
From web sources and news partners
Profile
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
About BioGaia AB
CEOTheresa Agnew
Employees251
Founded1990
Headquarters-
Sector-
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
326,64 млн
440,57 млн
372,55 млн
440,86 млн
Cost of goods sold
84,13 млн
116,74 млн
105,77 млн
119,98 млн
Cost of revenue
84,13 млн
116,74 млн
105,77 млн
119,98 млн
Research and development expenses
25,88 млн
36,79 млн
25,53 млн
28,24 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
126,67 млн
159,68 млн
145,89 млн
167,47 млн
Operating expense
152,54 млн
196,47 млн
171,42 млн
195,71 млн
Total operating expenses
236,68 млн
313,21 млн
277,19 млн
315,69 млн
Operating income
89,96 млн
127,36 млн
95,36 млн
125,17 млн
Other non operating income
1,00 мың
-2,39 млн
285,00 м.
-1,00 мың
EBT including unusual items
85,32 млн
123,58 млн
101,50 млн
134,03 млн
EBT excluding unusual items
87,52 млн
117,88 млн
103,78 млн
134,03 млн
Income tax expense
19,44 млн
24,80 млн
22,10 млн
30,88 млн
Effective tax rate
22,78%
20,07%
21,77%
23,04%
Other operating expenses
-
-
-
-
Net income
65,88 млн
98,78 млн
79,41 млн
103,16 млн
Net profit margin
20,17%
22,42%
21,32%
23,40%
Earnings per share
0,65
0,98
0,78
1,11
Interest and investment income
2,93 млн
2,81 млн
2,34 млн
2,01 млн
Interest expense
-1,39 млн
-3,49 млн
-
-62,00 мың
Net interest expenses
1,54 млн
-677,00 м.
2,34 млн
1,95 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
96,10 млн
133,49 млн
101,50 млн
131,21 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары